Regulations for the Inspection and Examination of Imported Medicaments Article 18
For inspection of medicaments, that are difficult to sample in a container yard, require five or more days for examination at the laboratory, perishable, or lack stability on safety efficacy, the inspection authority shall issue a Notice of Prior for Import for custom clearance after the obligatory inspection applicant declares to bear the responsibility for the safety and storage of products imported with an Affidavit. The inspection authority may issue a Notice of Prior Release for Import for customs clearance since the necessity of examination.If the pledged storage location does not conform to the actual storage location, or medicaments are put to use before receiving the import permit, the inspection authority may temporarily suspend acceptance of an application for prior release of imports by the obligatory inspection applicant for a period of 180 days.
中文原文 輸入藥物邊境抽查檢驗辦法第18條
查驗機關對於在貨櫃場取樣困難、檢驗時間超過五日、產品容易腐敗、變質或其安全功效穩定性不足之藥物,得於報驗義務人書立切結書表明負保管責任後,簽發輸入藥物先行放行通知書,供其辦理先行通關。
前項先行放行藥物,報驗義務人切結之存置地點與實際不符或於核發輸入許可通知之前即擅自啟用者,查驗機關得自發現日起一百八十日內,暫停受理該報驗義務人先行放行申請。
前項先行放行藥物,報驗義務人切結之存置地點與實際不符或於核發輸入許可通知之前即擅自啟用者,查驗機關得自發現日起一百八十日內,暫停受理該報驗義務人先行放行申請。